Under both Drake’s and Lynch’s versions, the cost of deleterious mutations is exactly what drives mutation costs down (Drake 1991; Lynch 2010; Sung et al. 2012). hence, under each types, a rise in the normal expense of mutations would result in a lower in mutation rates. To examine this, Drake examined mutation rates of thermophiles and in comp